Material Agreements

ARRAY DIGITAL INFRASTRUCTURE, INC. amended Fifth Amendment with Toronto Dominion (Texas) LLC, as administrative agent, and the other lenders (effective 2025-12-08).

“On December 8, 2025 (the “Effective Date”), Array Digital Infrastructure, Inc. (“Array”) entered into the Fifth Amendment (the “Amendment”) to First Amended and Restated Credit Agreement among Array, Toronto Dominion (Texas) LLC, as administrative agent, and the other lenders thereto (the “Credit Agreement”).”

CPI AEROSTRUCTURES INC terminated Amended and Restated Credit Agreement with BankUnited, N.A. valued at Repaid in full and terminated (effective 2025-12-12).

“On December 12, 2025, in connection with entering into the Loan Agreement and the Credit Facilities described in Item 1.01 of this Current Report on Form 8-K, the Company repaid in full all outstanding obligations under that certain Amended and Restated Credit Agreement, dated as of March 24, 2016, as amended, among the Company, the several lenders from time to time parties thereto and BankUnited, N.A., as sole arranger, administrative agent and collateral agent (the “ BankUnited Credit Agreement ”).”

CPI AEROSTRUCTURES INC entered into Loan and Security Agreement with Western Alliance Bank valued at $10,000,000 revolving line of credit and $10,000,000 term loan (effective 2025-12-12).

“On December 12, 2025, CPI Aerostructures, Inc. (the “ Company ”) entered into a Loan and Security Agreement (the “ Loan Agreement ”) with Western Alliance Bank (the “ Bank ”).”

LIGHTPATH TECHNOLOGIES INC entered into Underwriting Agreement with Canaccord Genuity LLC and Craig-Hallum Capital Group LLC, as representatives of the several underwriters valued at approximately $56.8 million (effective 2025-12-12).

“On December 12, 2025, LightPath Technologies, Inc., a Delaware corporation (the “Company”), entered into an underwriting agreement (the “Underwriting Agreement”) with Canaccord Genuity LLC and Craig-Hallum Capital Group LLC, as representatives of the several underwriters named therein”

Enveric Biosciences, Inc. entered into Inducement Letters with certain institutional investors valued at aggregate gross proceeds of approximately $3.1 million (effective 2025-12-11).

“On December 11, 2025, Enveric Biosciences, Inc., a Delaware corporation (the “Company”) entered into warrant exercise inducement offer letters (the “Inducement Letters”) with certain institutional investors (the “Holders”) that held certain outstanding warrants to purchase up to an aggregate of 426,390 shares originally issued in February 2025 and September 2025, having exercise prices of $36.00 and $10.98 per share, respectively (collectively, the “Existing Warrants”).”

STEWART INFORMATION SERVICES CORP entered into Underwriting Agreement with Goldman Sachs & Co. LLC (effective 2025-12-10).

“On December 10, 2025, Stewart Information Services Corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”), between the Company and Goldman Sachs & Co. LLC, as representative of the several underwriters listed on Schedule I thereto (the “Underwriters”), pursuant to which the Company agreed to issue and sell to the Underwriters 1,900,000 shares of common stock, par value $1.00 (“Common Stock”), in a registered public offering (the “Offering”) pursuant to an effective shelf registration statement on Form S-3 (Registration File No. 333-292051) (the “Shelf Registration Statement”).”

AFFILIATED MANAGERS GROUP, INC. amended Third Supplemental Indenture with U.S. Bank National Association and U.S. Bank Trust Company, National Association valued at $425,000,000 (effective 2025-12-11).

“On December 11, 2025, Affiliated Managers Group, Inc. (the “Company”) completed the issuance and sale of $425,000,000 aggregate principal amount of the Company’s 5.500% Senior Notes due 2036 (the “Securities”). The Securities were issued pursuant to a senior notes indenture, dated as of June 5, 2020 (the “Base Indenture”), as supplemented by the third supplemental indenture thereto, dated as of December 11, 2025 (the “Third Supplemental Indenture””

AFFILIATED MANAGERS GROUP, INC. entered into Underwriting Agreement with BofA Securities, Inc., Citigroup Global Markets Inc. and Wells Fargo Securities, LLC (effective 2025-12-08).

“On December 8, 2025, the Company also entered into an underwriting agreement (the “Underwriting Agreement”) with BofA Securities, Inc., Citigroup Global Markets Inc. and Wells Fargo Securities, LLC, as representatives of the underwriters named therein.”

STEELCASE INC terminated Fourth Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A., Bank of America, N.A., HSBC Bank USA, National Association, and the lenders party thereto.

“Steelcase terminated all credit commitments outstanding under the Fourth Amended and Restated Credit Agreement (the “ Credit Agreement ”), dated as of February 7, 2024, by and among Steelcase, the subsidiary borrowers from time to time party thereto, the institutions from time to time party thereto as lenders, JPMorgan Chase Bank, N.A., as the Administrative Agent, Bank of America, N.A., as Syndication Agent, and HSBC Bank USA, National Association, as Documentation Agent and paid (or caused to be paid) all outstanding fees, expenses and other Obligations (as defined in the Credit Agreement) owing under the Credit Agreement.”

Greystone Housing Impact Investors LP terminated Amended and Restated Capital on Demand TM Sales Agreement with JonesTrading Institutional Services LLC and BTIG, LLC valued at $50,000,000 (effective 2025-12-11).

“Effective December 11, 2025, Greystone Housing Impact Investors LP (the “Partnership”) terminated the certain Amended and Restated Capital on Demand TM Sales Agreement dated March 8, 2024 (the “Sales Agreement”) between the Partnership and JonesTrading Institutional Services LLC and BTIG, LLC, as agents (each an “Agent,” and collectively the “Agents”) in accordance with the terms of such agreement.”

AppTech Payments Corp. amended Amendment to Senior Unsecured Convertible Promissory Note with Eleven 11 Management LLC (effective 2025-12-04).

“On December 4, 2025, AppTech Payments Corp., a Delaware corporation (the “Company”), entered into an Amendment to Senior Unsecured Convertible Promissory Note (the “Amendment”), by and between the Company and Eleven 11 Management LLC (the “Holder”), amending that certain Senior Unsecured Convertible Promissory Note in favor of the Holder, dated as of June 18, 2025 (the “Original Note”) in the original principal amount of Three Hundred Sixty Thousand and 00/100 Dollars ($360,000.00) (the Original Note as amended by the Amendment, “the Note”).”

Modular Medical, Inc. entered into Underwriting Agreement with Newbridge Securities Corporation valued at approximately $4.68 million (effective 2025-12-10).

“On December 10, 2025, Modular Medical, Inc. (the “Company”) entered into an Underwriting Agreement (the “Agreement”) with Newbridge Securities Corporation (the “Underwriter”), relating to a firm commitment underwritten offering (the “Offering”) of (i) 12,173,000 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), referred to as the “Firm Shares,” and (ii) accompanying warrants exercisable to purchase up to 6,086,500 shares of Common Stock (the “Warrants”), referred to as the “Firm Warrants.””

Worksport Ltd entered into Inducement Letter with a certain holder (the “Holder”) of existing warrants valued at approximately $6,400,000 (effective 2025-12-11).

“On December 11, 2025, Worksport Ltd., a Nevada corporation (the “Company”), entered into a common stock warrant exercise inducement offer letter (the “Inducement Letter”) with a certain holder (the “Holder”) of existing warrants to purchase shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at a weighted average exercise price of $6.82, issued on March 20, 2024 and March 3, 2025, respectively (the “Existing Warrants”). Pursuant to the Inducement Letter, the Holder agreed to exercise for cash its Existing Warrants to purchase an aggregate of 2,194,526 shares of Common Stock at a reduced exercise price of $2.90 per share, in consideration for the Company’s agreement to issue new warrants (the “Inducement Warrants”) having terms as described below, to purchase up to 3,840,421 shares of Common Stock (the “Inducement Warrant Shares”). The Company expects to receive aggregate gross proceeds of approximately $6,400,000 from the exercise of the Existing War”

NISOURCE INC. entered into Seventh Amended and Restated Revolving Credit Agreement with Barclays Bank PLC valued at Increased facility to $2.5 billion and extended termination date to December 11, 2030 (effective 2025-12-11).

“On December 11, 2025, NiSource Inc. (“NiSource”), as Borrower, entered into a Seventh Amended and Restated Revolving Credit Agreement (the “Agreement”) with the lenders party thereto, Barclays Bank PLC, as Administrative Agent, JPMorgan Chase Bank, N.A., MUFG Bank, Ltd. and Wells Fargo Bank, National Association, as Co-Syndication Agents, Bank of America, National Association, Bank of Montreal and Mizuho Bank, Ltd., as Co-Documentation Agents, and Barclays Bank PLC, JPMorgan Chase Bank, N.A., MUFG Bank, Ltd., Wells Fargo Securities, LLC, BofA Securities, Inc., BMO Capital Markets Corp. and Mizuho Bank, Ltd., as Joint Lead Arrangers and Joint Bookrunners.”

DIRTT ENVIRONMENTAL SOLUTIONS LTD entered into Letter with Business Development Bank of Canada valued at C$15.0 million (effective 2025-12-11).

“On December 11, 2025, DIRTT Environmental Solutions Ltd. (the “Company”) entered into a letter of offer (the “Letter”) with Business Development Bank of Canada (“BDC”) pursuant to which BDC committed to lending the Company up to C$15.0 million (the “Loan”) subject to the satisfaction of certain conditions.”

Philip Morris International Inc. amended Amendment and Extension Agreement with the lenders named therein and Citibank Europe plc, UK Branch, as facility agent valued at €1.5 billion (effective 2025-12-11).

“On December 11, 2025, PMI also entered into an agreement, effective as of January 29, 2026 (the “Amendment and Extension Agreement”), to amend and extend the term of its existing €1.5 billion revolving credit facility, dated December 17, 2024 (the “2024 Credit Agreement”) with the lenders named therein and Citibank Europe plc, UK Branch, as facility agent.”

Philip Morris International Inc. terminated Terminating Facility with the lenders named therein, Citibank Europe plc, UK Branch, as facility agent, and Citibank, N.A., as swingline agent valued at US$2.0 billion (effective 2025-12-11).

“PMI provided notice of termination of the Terminating Facility on December 11, 2025, with termination effective as of January 29, 2026, conditional upon the effectiveness of the Credit Agreement.”

Philip Morris International Inc. entered into Credit Agreement with the lenders named therein, Citibank Europe plc, UK Branch, as facility agent, and Citibank, N.A., as swingline agent valued at US$2.0 billion (effective 2025-12-11).

“On December 11, 2025, Philip Morris International Inc. (“PMI”) entered into a credit agreement, effective as of January 29, 2026 (the “Credit Agreement”), relating to a senior unsecured revolving credit facility (the “Facility”) with the lenders named therein, Citibank Europe plc, UK Branch, as facility agent, and Citibank, N.A., as swingline agent.”

Rein Therapeutics, Inc. terminated Standby Equity Purchase Agreement with YA II PN, Ltd. (effective 2025-12-11).

“On December 11, 2025, Rein Therapeutics, Inc. (the “Company”) elected to terminate the Pre-Paid Advance Agreement (the “PPA”) dated July 29, 2025 with YA II PN, Ltd., a Cayman Islands exempt limited partnership (“Yorkville”), and the Standby Equity Purchase Agreement (the “SEPA”) dated July 29, 2025 also entered into with Yorkville.”

Rein Therapeutics, Inc. terminated Pre-Paid Advance Agreement with YA II PN, Ltd. (effective 2025-12-11).

“On December 11, 2025, Rein Therapeutics, Inc. (the “Company”) elected to terminate the Pre-Paid Advance Agreement (the “PPA”) dated July 29, 2025 with YA II PN, Ltd., a Cayman Islands exempt limited partnership (“Yorkville”), and the Standby Equity Purchase Agreement (the “SEPA”) dated July 29, 2025 also entered into with Yorkville.”

ENTERGY TEXAS, INC. entered into Lease with BA Leasing BSC, LLC (effective 2025-12-09).

“On December 9, 2025, Entergy Texas, Inc. (“Entergy Texas”) entered into certain agreements related to the construction and leasing of a planned 754-megawatt combined cycle gas power plant, Legend Power Station, in Jefferson County, Texas (the “Facility” and, together with the ground site, the “Leased Property”). Among others, those agreements included (collectively, the “Transaction Documents”): • a Participation Agreement (the “Participation Agreement”) among Entergy Texas, as Lessee and Construction Agent, BA Leasing BSC, LLC (“BAL”), as Lessor, Bank of America, N.A., acting in the capacity as Administrative Agent, and the persons named on Schedule II thereto, as “Rent Assignees” (together with BAL, the “Participants”); • a Construction Agency Agreement (the “Construction Agency Agreement”) between Entergy Texas, as Construction Agent, and BAL, as Lessor; and • a Lease, Deed of Trust and Security Agreement (the “Lease”) between Entergy Texas, as Lessee, and BAL, as Lessor.”

ENTERGY TEXAS, INC. entered into Construction Agency Agreement with BA Leasing BSC, LLC (effective 2025-12-09).

“On December 9, 2025, Entergy Texas, Inc. (“Entergy Texas”) entered into certain agreements related to the construction and leasing of a planned 754-megawatt combined cycle gas power plant, Legend Power Station, in Jefferson County, Texas (the “Facility” and, together with the ground site, the “Leased Property”). Among others, those agreements included (collectively, the “Transaction Documents”): • a Participation Agreement (the “Participation Agreement”) among Entergy Texas, as Lessee and Construction Agent, BA Leasing BSC, LLC (“BAL”), as Lessor, Bank of America, N.A., acting in the capacity as Administrative Agent, and the persons named on Schedule II thereto, as “Rent Assignees” (together with BAL, the “Participants”); • a Construction Agency Agreement (the “Construction Agency Agreement”) between Entergy Texas, as Construction Agent, and BAL, as Lessor;”

ENTERGY TEXAS, INC. entered into Participation Agreement with BA Leasing BSC, LLC and Bank of America, N.A. valued at $1.450 billion (effective 2025-12-09).

“On December 9, 2025, Entergy Texas, Inc. (“Entergy Texas”) entered into certain agreements related to the construction and leasing of a planned 754-megawatt combined cycle gas power plant, Legend Power Station, in Jefferson County, Texas (the “Facility” and, together with the ground site, the “Leased Property”). Among others, those agreements included (collectively, the “Transaction Documents”): • a Participation Agreement (the “Participation Agreement”) among Entergy Texas, as Lessee and Construction Agent, BA Leasing BSC, LLC (“BAL”), as Lessor, Bank of America, N.A., acting in the capacity as Administrative Agent, and the persons named on Schedule II thereto, as “Rent Assignees” (together with BAL, the “Participants”); • a Construction Agency Agreement (the “Construction Agency Agreement”) between Entergy Texas, as Construction Agent, and BAL, as Lessor; and • a Lease, Deed of Trust and Security Agreement (the “Lease”) between Entergy Texas, as Lessee, and BAL, as Lessor. Costs of c”

CEMTREX INC entered into Securities Purchase Agreement valued at $2,000,000 (effective 2025-12-11).

“On December 11, 2025, Cemtrex, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a single accredited institutional investor (the “Purchaser”), pursuant to which the Company agreed to issue and sell to the Purchaser, in a registered direct offering (the “Offering”), securities consisting of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and/or pre-funded warrants to purchase shares of Common Stock (the “Pre-Funded Warrants”), for aggregate gross proceeds of $2,000,000.”

Horizon Technology Finance Corp entered into Underwriting Agreement with Oppenheimer & Co. Inc. valued at $57.5 million (effective 2025-12-11).

“On December 11, 2025, Horizon Technology Finance Corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) by and among the Company, Horizon Technology Finance Management LLC and Oppenheimer & Co. Inc. in connection with the issuance and sale of $57.5 million aggregate principal amount of the Company’s 7.00% Notes due 2028 (the “Offering”).”

Contango Silver & Gold Inc. entered into Arrangement Agreement with Dolly Varden Silver Corporation (effective 2025-12-07).

“On December 7, 2025, Contango ORE, Inc. (the “Company”) and its newly formed subsidiary, 1566004 B.C. Ltd. (the “Acquiror”), a British Columbia corporation directly and wholly-owned by newly formed subsidiary, 1566002 B.C. ULC (“Callco”), a British Columbia unlimited liability company directly and wholly-owned by the Company, entered into an Arrangement Agreement (the “Agreement”) with Dolly Varden Silver Corporation, a British Columbia corporation (“Dolly Varden”).”

Arq, Inc. amended Second Amendment with MidCap Funding IV Trust, in its capacity as agent, the lenders from time to time party thereto, and any entities that become party thereto as Guarantors (effective 2025-12-09).

“On December 9, 2025 , Arq, Inc. (the "Company") and certain of its subsidiaries, entered into the second amendment (the "Second Amendment") to the Credit, Security and Guaranty Agreement (the "Revolving Credit Agreement"), dated December 27, 2024, as amended on May 6, 2025, with MidCap Funding IV Trust, in its capacity as agent, the lenders from time to time party thereto, and any entities that become party thereto as Guarantors.”

Matador Resources Co amended Seventh Amendment to Fourth Amended and Restated Credit Agreement (effective 2025-12-09).

“On December 9, 2025, MRC Energy Company (“MRC Energy”), a wholly-owned subsidiary of Matador Resources Company (“Matador”), entered into a Seventh Amendment to Fourth Amended and Restated Credit Agreement (the “Amendment”), which amended Matador’s existing secured revolving credit facility (the “Credit Agreement”) to, among other things: (i) remove the 0.10% per annum credit spread adjustment that was previously included in the calculation of the Adjusted Daily Simple SOFR and Adjusted Term SOFR Rate (each as defined in the Credit Agreement) applicable to all interest periods under the Credit Agreement, (ii) reaffirm the borrowing base at $3.25 billion and (iii) maintain the elected borrowing commitments at $2.25 billion.”

Enova International, Inc. entered into Agreement and Plan of Merger with Grasshopper Bancorp, Inc. valued at approximately $350 million (effective 2025-12-10).

“On December 10, 2025, Enova International, Inc. (“Enova”), a Delaware corporation, and Grasshopper Bancorp, Inc. (“Grasshopper”), a Delaware corporation and the parent holding company of Grasshopper Bank N.A. (“Grasshopper Bank”), a national bank and wholly-owned subsidiary of Grasshopper, entered into an Agreement and Plan of Merger (the “Merger Agreement”).”

National Healthcare Properties, Inc. entered into Credit Agreement with Wells Fargo Bank, National Association, as administrative agent, and certain lenders party thereto valued at $400 million senior unsecured revolving credit facility and a $150 million senior unsecured term loa (effective 2025-12-11).

“On December 11, 2025, National Healthcare Properties, Inc. (the “Company”), as guarantor, National Healthcare Properties Operating Partnership, L.P. (the “Operating Partnership”), as borrower, and certain indirect subsidiaries of the Company entered into a credit agreement (the “Credit Agreement”) with Wells Fargo Bank, National Association, as administrative agent, and certain lenders party thereto.”

REALLOYS INC. amended Third Amendment to Agreement and Plan of Merger with Blackboxstocks Inc., RABLBX Merger Sub inc. (Merger Sub), and REalloys Inc. (effective 2025-12-10).

“On December 10, 2025, Blackboxstocks, Merger Sub and REalloys entered into a Third Amendment to Agreement and Plan of Merger (the “Third Amendment”)”

Hilton Worldwide Holdings Inc. terminated 2028 Notes Indenture valued at $500 million (effective 2025-12-11).

“On December 11, 2025, the Issuer completed the redemption in full of all of the $500 million aggregate principal amount of issued and outstanding 2028 Notes at a redemption price of 100.00% of the outstanding aggregate principal amount, plus accrued and unpaid interest to, but excluding, the redemption date.”

Hilton Worldwide Holdings Inc. entered into Indenture with Wilmington Trust, National Association valued at $1 billion (effective 2025-12-10).

“On December 10, 2025, Hilton Domestic Operating Company Inc. (the “Issuer”), an indirect subsidiary of Hilton Worldwide Holdings Inc. (the “Company”), issued and sold $1 billion aggregate principal amount of 5.500% Senior Notes due 2034 (the “Notes”) under an Indenture, dated as of December 10, 2025 (the “Indenture”), by and among the Issuer, the Company, as a guarantor, the other guarantors party thereto and Wilmington Trust, National Association, as trustee (in such capacity, the “Trustee”).”

Sabre Corp entered into SPV Notes Indenture with Wilmington Trust, National Association valued at $1 billion (effective 2025-12-05).

“On December 5, 2025 (the “SPV Notes Issue Date”), Sabre Financial Borrower, LLC (“Sabre Financial”), an indirect wholly-owned subsidiary of Sabre Corporation (“Sabre” or the “Company”), Sabre Financing Holdings LLC (“Sabre Financing”), Sabre Financial’s direct parent company, certain of Sabre’s Luxembourg subsidiaries and Wilmington Trust, National Association, as trustee and collateral agent, entered into an indenture (the “SPV Notes Indenture”) governing Sabre Financial’s newly issued 11.125% senior secured notes due 2029 (the “SPV Notes”).”

JOINT Corp terminated Elite Chiro Group Purchase Agreement with Elite Chiro Group, Gadi Emein valued at $4.5 million (effective 2025-12-11).

“On December 11, 2025, we delivered a notice of termination (the “Elite Chiro Group Termination Notice”) to terminate the Asset Purchase Agreement, dated November 2, 2025 (the “Elite Chiro Group Purchase Agreement”), between us, Elite Chiro Group, a California corporation (“Elite Chiro Group”), as buyer, and Gadi Emein, an individual, as guarantor, pursuant to which we would have sold to Elite Chiro Group the assets of, and granted franchise rights to, 45 company-owned or managed clinics located in Southern California for an aggregate purchase price of $4.5 million, subject to certain adjustments.”

JOINT Corp entered into Southeast Purchase Agreement with Addisco Value, LLC, Triangle Chiropractic Associates P.C., Bluffton TJ, LLC, Alex Klaus, Todd Wegerski, DC, Lisa Ezell, Andrew Michael Evec, Susan Ruth Train valued at $1,482,800 (effective 2025-12-05).

“On December 5, 2025, we entered into an Asset Purchase Agreement (as amended, the “Southeast Purchase Agreement”) with Addisco Value, LLC, a North Carolina limited liability company, Triangle Chiropractic Associates P.C., a North Carolina professional corporation, and Bluffton TJ, LLC, a South Carolina limited liability company (collectively, the “Buyers”), and Alex Klaus, an individual, Todd Wegerski, DC, an individual, Lisa Ezell, an individual, Andrew Michael Evec, an individual, and Susan Ruth Train, an individual (collectively, the “Guarantors”), pursuant to which we will sell to the Buyers the assets of, and grant franchise rights to, 22 company-owned or managed clinics located in Virginia, North Carolina and South Carolina (the “Southeast Transaction”) for an aggregate purchase price of $1,482,800, subject to certain adjustments (the “Purchase Price”).”

Wave Life Sciences Ltd. entered into Underwriting Agreement with Jefferies LLC, Leerink Partners LLC and BofA Securities, Inc. valued at approximately $402.5 million (effective 2025-12-09).

“On December 9, 2025, Wave Life Sciences Ltd. (the “Company,” “we” or “us”) entered into an underwriting agreement (the “Underwriting Agreement”) with Jefferies LLC, Leerink Partners LLC and BofA Securities, Inc., as representatives of the several underwriters named therein”

Arteris, Inc. entered into Agreement and Plan of Merger and Reorganization with Cycuity, Inc. valued at up to $45,000,000 (effective 2025-12-10).

“On December 10, 2025, Arteris, Inc., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) with Cabernet Merger Sub I, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“Merger Sub I”), Arteris Security, LLC, a Delaware limited liability company and wholly-owned subsidiary of the Company (“Merger Sub II”), Cycuity, Inc., a Delaware corporation (“Cycuity”), and Shareholder Representative Services LLC, solely in its capacity as Holder Representative, as defined in the Merger Agreement.”

Kinsale Capital Group, Inc. entered into Amendment No. 3 to the Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent and as a lender, Truist Bank, as a lender, and CIBC Bank USA, as a lender valued at amends Section 6.08(f) of the Amended and Restated Credit Agreement to permit Restricted Payments (a (effective 2025-12-11).

“On December 11, 2025, Kinsale Capital Group, Inc. (the “Company”) entered into: • the Third Amendment to the Note Purchase and Private Shelf Agreement (the “NPA Amendment”) with PGIM, Inc. and the other noteholders party thereto; and • Amendment No. 3 to the Amended and Restated Credit Agreement (the “Credit Agreement Amendment”) with JPMorgan Chase Bank, N.A., as administrative agent and as a lender, Truist Bank, as a lender, and CIBC Bank USA, as a lender.”

Kinsale Capital Group, Inc. entered into Third Amendment to the Note Purchase and Private Shelf Agreement with PGIM, Inc. and the other noteholders party thereto valued at amends Section 6H of the Original Agreement to permit Restricted Payments so long as at the time of (effective 2025-12-11).

“On December 11, 2025, Kinsale Capital Group, Inc. (the “Company”) entered into: • the Third Amendment to the Note Purchase and Private Shelf Agreement (the “NPA Amendment”) with PGIM, Inc. and the other noteholders party thereto; and • Amendment No. 3 to the Amended and Restated Credit Agreement (the “Credit Agreement Amendment”) with JPMorgan Chase Bank, N.A., as administrative agent and as a lender, Truist Bank, as a lender, and CIBC Bank USA, as a lender.”

Fulcrum Therapeutics, Inc. entered into Underwriting Agreement with J.P. Morgan Securities LLC, Leerink Partners LLC, and Cantor Fitzgerald & Co. (effective 2025-12-10).

“On December 10, 2025, Fulcrum Therapeutics, Inc., or Fulcrum, entered into an underwriting agreement, or the Underwriting Agreement, with J.P. Morgan Securities LLC, Leerink Partners LLC, and Cantor Fitzgerald & Co., as the representatives of the several underwriters, or the Underwriters, relating to an underwritten public offering”

TALOS ENERGY INC. amended Amendment with Control Empresarial de Capitales, S.A. de C.V. (effective 2025-12-08).

“On December 8, 2025, Talos Energy Inc. (the “ Company ”) entered into an amendment (the “Amendment”) to the Cooperation Agreement dated as of December 16, 2024 (“ Cooperation Agreement ”) with Control Empresarial de Capitales, S.A. de C.V. (“ Control Empresarial ”)”

Climb Bio, Inc. entered into Exchange Agreement with RA Capital Management, L.P. and an entity affiliated with RA Capital (effective 2025-12-11).

“On December 11, 2025, Climb Bio, Inc. (the “Company”) entered into an exchange agreement (the “Exchange Agreement”) with RA Capital Management, L.P. (“RA Capital”) and an entity affiliated with RA Capital (the “Exchanging Stockholder”), pursuant to which the Exchanging Stockholder agreed to exchange (the “Exchange”) an aggregate of 20,440,000 shares of the Company’s common stock”

CoreWeave, Inc. entered into Indenture with U.S. Bank Trust Company, National Association valued at $2,587,500,000 aggregate principal amount (effective 2025-12-11).

“On December 11, 2025, CoreWeave, Inc. (“CoreWeave”) completed its previously announced private offering of $2,587,500,000 aggregate principal amount of its 1.75% Convertible Senior Notes due 2031 (the “Notes”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”) including the exercise in full of the initial purchasers’ option to purchase up to an additional $337,500,000 aggregate principal amount of the Notes. The Notes were issued pursuant to an Indenture, dated December 11, 2025 (the “Indenture”), among CoreWeave, the Guarantors (as defined below) party thereto and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”).”

Valion Bio, Inc. entered into Security Agreement with 3i, LP valued at security interests granted in collateral for $16,253,147.10 note (effective 2025-12-09).

“On December 9, 2025, the Company, VBI and 3i entered into a Security Agreement (the “Security Agreement”), pursuant to which the Company and VBI granted security interests in the Collateral (as such term is defined in the Security Agreement) to secure the obligations of the Company under the Note and the Note Purchase Agreement.”

Valion Bio, Inc. entered into Securities Purchase Agreement with 3i, LP valued at $16,253,147.10 (effective 2025-12-09).

“On December 9, 2025, the Company entered into a Securities Purchase Agreement (the “Note Purchase Agreement”) with 3i, pursuant to which the Company agreed to issue, in a private placement, upon the satisfaction of certain conditions specified in the Note Purchase Agreement, a senior secured convertible note (the “Note”) in the principal amount of $16,253,147.10 and a warrant (the “Note Offering Warrant”) to purchase up to an aggregate of 4,553,213 shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), to 3i for an aggregate purchase price of $16,253,147.10 (the “Note Offering”).”

Valion Bio, Inc. entered into Asset Purchase Agreement with 3i, LP valued at $16,253,147.10 (effective 2025-12-09).

“On December 9, 2025, Tivic Health Systems, Inc. (the “Company”), a Delaware corporation, through a newly formed wholly owned subsidiary, Velocity Bioworks, Inc. (“VBI”) entered into an Asset Purchase Agreement (the “APA”) and Secured Party Bill of Sale (the “Bill of Sale”) with 3i, LP (“3i”), in its capacity as collateral agent (“Collateral Agent”) of Scorpius Holdings, Inc. (“Scorpius”) pursuant to which, VBI acquired all of personal property and assets (collectively, the “Acquired Assets”), but assumed no liabilities in respect to the period prior to the Closing Date (as defined below) of Scorpius, in a public sale pursuant to Article 9 of the Uniform Commercial Code (“Article 9”) (the “Acquisition”).”

Apollo Debt Solutions BDC amended Seventh Credit Facility Amendment with Citibank, N.A., as administrative agent, and The Bank of New York Mellon Trust Company, National Association, as collateral agent, custodian and collateral administrator (effective 2025-12-08).

“On December 8, 2025, Cardinal Funding LLC (“Cardinal Funding”), a wholly owned subsidiary of Apollo Debt Solutions BDC, a Delaware statutory trust (the “Company”) entered into Amendment No. 7 (the “Seventh Credit Facility Amendment”) to its Credit and Security Agreement (the “Secured Credit Facility”), dated as of January 7, 2022, by and among Cardinal Funding, as borrower, the Company, in its capacity as collateral manager and in its capacity as equityholder, the lenders from time to time parties thereto, Citibank, N.A., as administrative agent, and The Bank of New York Mellon Trust Company, National Association, as collateral agent, custodian and collateral administrator.”

Cadrenal Therapeutics, Inc. entered into Asset Purchase Agreement with Veralox Therapeutics Inc. valued at $200,000 (effective 2025-12-10).

“On December 10, 2025, Cadrenal Therapeutics, Inc., a Delaware corporation (the “Company”) entered into an Asset Purchase Agreement (the “Purchase Agreement”) with Veralox Therapeutics Inc., a Delaware corporation (“Seller”)”

Bunge Global SA amended Twenty-Ninth Amendment to the Receivables Transfer Agreement with Coöperatieve Rabobank U.A. (effective 2025-12-05).

“On December 5, 2025, Bunge Global SA (“Bunge”) and certain of its subsidiaries amended Bunge’s existing trade receivables securitization program (the “Securitization Program”) with Coöperatieve Rabobank U.A., as administrative agent, and certain commercial paper conduit purchasers and committed purchasers (the “Purchasers”) pursuant to the Twenty-Ninth Amendment to the Receivables Transfer Agreement (the “Twenty-Ninth Amendment to the RTA”).”